Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans

Enavogliflozin is a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor approved for clinical use in South Korea. As SGLT2 inhibitors are a treatment option for patients with diabetes, enavogliflozin is expected to be prescribed in various populations. Physiologically based pharmacokinetic (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min-Soo, Song, Yoo-Kyung, Choi, Ji-Soo, Ji, Hye Young, Yang, Eunsuk, Park, Joon Seok, Kim, Hyung Sik, Kim, Min-Joo, Cho, In-Kyung, Chung, Suk-Jae, Chae, Yoon-Jee, Lee, Kyeong-Ryoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058973/
https://www.ncbi.nlm.nih.gov/pubmed/36986803
http://dx.doi.org/10.3390/pharmaceutics15030942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058973/
https://www.ncbi.nlm.nih.gov/pubmed/36986803
http://dx.doi.org/10.3390/pharmaceutics15030942

Ejemplares similares